Cypress Capital Management (Wyoming)’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.5K	Hold	780	–	–	0.06%	84
2025 Q4	$66.5K	Sell	780 -50	-6%	-$4.1K	0.06%	78
2025 Q3	$64.5K	Hold	830	–	–	0.06%	81
2025 Q2	$64.9K	Hold	830	–	–	0.07%	79
2025 Q1	$60.2K	Hold	830	–	–	0.07%	77
2024 Q4	$61.4K	Hold	830	–	–	0.07%	74
2024 Q3	$54.8K	Sell	830 -125	-13%	-$9.08K	0.06%	78
2024 Q2	$88.2K	Hold	955	–	–	0.09%	66
2024 Q1	$91.3K	Hold	955	–	–	0.1%	60
2023 Q4	$72.8K	Hold	955	–	–	0.08%	66
2023 Q3	$66.2K	Hold	955	–	–	0.08%	65
2023 Q2	$90.1K	Hold	955	–	–	0.1%	58
2023 Q1	$79K	Hold	955	–	–	0.09%	62
2022 Q4	$71.3K	Sell	955 -750	-44%	-$57.8K	0.09%	62
2022 Q3	$141K	Hold	1,705	–	–	0.2%	42
2022 Q2	$162K	Hold	1,705	–	–	0.21%	41
2022 Q1	$201K	Hold	1,705	–	–	0.24%	44
2021 Q4	$221K	Sell	1,705 -2,025	-54%	-$236K	0.19%	68
2021 Q3	$422K	Hold	3,730	–	–	0.35%	50
2021 Q2	$386K	Hold	3,730	–	–	0.3%	58
2021 Q1	$312K	Sell	3,730 -30,918	-89%	-$2.61M	0.27%	64
2020 Q4	$3.16M	Sell	34,648 -30,860	-47%	-$2.56M	2.74%	5
2020 Q3	$5.5M	Sell	65,508 -490	-0.7%	-$38.2K	4.94%	3
2020 Q2	$4.56M	Sell	65,998 -1,670	-2%	-$119K	4.56%	3
2020 Q1	$4.25M	Sell	67,668 -4,518	-6%	-$326K	5.99%	3
2019 Q4	$5.61M	Buy	+72,186	New	+$5.64M	5.3%	3
2018 Q3	–	Sell	-35,925	Closed	-$1.74M	–	348
2018 Q2	$1.74M	Buy	+35,925	New	+$1.68M	1.83%	13
2017 Q3	–	Sell	-7,935	Closed	-$313K	–	273
2017 Q2	$313K	Buy	+7,935	New	+$290K	0.36%	53